Physician profile
Phillip Connors
NPI 1114543642
$1,791.95
in general payments reported to CMS, 2019-2025
14 companies · $768 in 2025
The $768 reported for 2025 was more than what 75% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $186 · 2022: $227 · 2023: $280 · 2024: $331 · 2025: $768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $480.71 | 2021-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Alkermes, INC. | $362.39 | 2021-2025 | Lybalvi, Aristada |
| Axsome Therapeutics, INC. | $181.91 | 2023-2024 | Auvelity |
| Supernus Pharmaceuticals, INC. | $117.00 | 2024-2025 | Qelbree |
| Janssen Pharmaceuticals, INC | $99.89 | 2023-2025 | Spravato, Invega Sustenna |
| Neurocrine Biosciences, INC. | $90.74 | 2024-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $88.25 | 2025 | Fanapt, Hetlioz |
| Lundbeck LLC | $85.45 | 2021-2025 | Rexulti, Abilify Maintena |
| Corium, LLC | $72.37 | 2024-2025 | Azstarys |
| Abbvie INC. | $55.87 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $51.50 | 2025 | Jornay Pm |
| E.R. Squibb & Sons, L.L.C. | $42.69 | 2025 | Cobenfy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $42.42 | 2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $20.76 | 2023 | Austedo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Connors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.